Recovery Housing and The National Drug Control Strategy by David K. Mineta

Report
Recovery Housing and
The National Drug
Control Strategy
David K. Mineta
Deputy Director, Demand Reduction
Office of National Drug Control Policy (ONDCP)
Presented at the Second Annual Ohio Recovery Housing Conference
Salt Fork State Park
Lore City, Ohio
September 24, 2014
Office of National Drug Control Policy
• Component of the Executive Office of
the President
• Coordinates drug-control activities and
related funding across the Federal
Government
• Produces the annual National Drug
Control Strategy
National Drug Control Strategy
•
The President’s science-based plan to
reform drug policy:
1) Prevent drug use before it ever begins through
education
2) Expand access to treatment for Americans
struggling with addiction
3) Reform our criminal justice system
4) Support Americans in recovery
•
Coordinated Federal effort on
112 action items
•
Signature initiatives:
– Prescription Drug Abuse
– Prevention
– Drugged Driving
The Need
• In 2013, 21.6 million Americans aged 12 or older had a past
year substance use disorder.1
• More than 1 of 3 (17.3 percent) young adults aged 18 to 25 had
a past year substance use disorder.1
• Long “addiction careers,” multiple episodes of treatment, and a
median of nine years from first contact with public treatment
system to one year of abstinence.2
• Overdose epidemic: More than 38,000 drug overdose deaths in
2010, approximately 22,000 involving RX drugs (76 percent of
RX overdoses from opioids).3
1
SAMHSA (2014). Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings.
2
Dennis, M.L. et al. (2007). The duration and correlates of addiction and treatment careers. Journal of Substance Abuse Treatment. 28
Suppl 1:S51-62.
3 CDC,
2012.
National Center for Health Statistics. Multiple Cause of Death 1999-2010 on CDC WONDER Online Database. Extracted May 1,
Persons Aged 12 or Older Needing Treatment
for Illicit Drug or Alcohol Use and Obtaining
Specialty Treatment, 2013
Did Not Receive
Treatment
(20.2 million)
Received Specialty
Treatment
(2.5 million)
89%
11%
22.7 Million Needing Treatment* for Illicit Drug or Alcohol Use
*Treatment need is defined as having a substance use disorder or receiving treatment at a specialty facility
within the past 12 months.
Source: SAMHSA, 2013 National Survey on Drug Use and Health (September 2014).
SAMHSA Recovery Framework
Recovery Housing Supports All Four SAMHSA Dimensions of Recovery
Dimensions of Recovery
1. Health: overcoming or
2. Home: a stable place to live.
managing one’s disease(s) or
symptoms—for example, abstaining
from use of alcohol, illicit drugs, and
non-prescribed medications …
making informed, healthy choices.
3. Purpose: meaningful daily
4. Community: relationships and
activities, such as a job, school,
volunteerism, family caretaking, or
creative endeavors, and the
independence, income and
resources to participate in society.
social networks that provide support,
friendship, love, and hope.
Source of SAMHSA Dimensions: http://blog.samhsa.gov/2012/03/23/defintion-of-recovery-updated/
What We Need to Know
• What recovery housing (RH) models are currently in use?
• What is the best way of classifying models for
practical/clinical and research purposes?
• What is the relative effectiveness of various RH models?
• Can models be matched with populations?
• What is the relative effectiveness and cost-effectiveness
of RH offered in conjunction with various other services?
• Is there a relationship between how RH is paid for and its
effectiveness?
• What our options for creating recovery housing in
federally subsidized settings, such as public housing
authorities.
Challenges
• Developing local & municipal government partners,
communities, and neighborhoods.
• Standards:
– Staffing, physical plant/safety (building code), siting/zoning, owner
operator requirements
– Cost/reimbursement
– NIMBYism
• Expanding partnerships with CJS, state and local
substance abuse and mental health authorities, and
segments of health care system.
• Developing and evaluating public and private
reimbursement mechanisms.
• Leveraging Federal housing programs to expand
capacity.
• Integrating people in medication-assisted treatment.
Q & A / Discussion
David K. Mineta
Deputy Director, Demand Reduction
Office of National Drug Control Policy
[email protected]
WhiteHouse.gov/ONDCP

similar documents